A clinician's guide to X-linked hypophosphatemia.

Area of Science:

• Endocrinology
• Genetics
• Pediatrics

Background:

• X-linked hypophosphatemia (XLH) is the most common heritable rickets and a primary disorder of renal phosphate wasting.
• Concerns exist regarding limited information and treatment guidelines, leading to potential misdiagnosis and mismanagement of XLH.
• A need for accessible clinical guidance was identified at the Advances in Rare Bone Diseases Scientific Conference.

Purpose of the Study:

• To address the need for concise and accessible treatment guidelines for clinicians managing XLH.
• To disseminate expert recommendations based on accumulated clinical experience.
• To improve the diagnosis and management of this complex genetic disorder.

Main Methods:

• Review of clinical and pathophysiologic features of XLH.
• Synthesis of collective expert experience in XLH management.
• Development of a treatment guide in response to a scientific conference recommendation.

Main Results:

• The abstract outlines the development of a treatment guide for XLH.
• It emphasizes the importance of addressing the lack of information and guidelines for this rare disease.
• The guide aims to improve clinical practice in managing XLH.

Conclusions:

• Accessible treatment guidelines are crucial for the effective management of X-linked hypophosphatemia.
• This perspective provides a much-needed resource for clinicians dealing with XLH.
• Improved understanding and standardized management can lead to better patient outcomes for XLH.